CXCL12 and neoplasm: Inhibition of hypoxia-induced factors like HIF-1α and SDF-1α—upregulated during anti-VEGF therapy—also limits TAM infiltration and enhances tumor sensitivity to radiotherapy and anti-angiogenic treatment [24].